Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy
NCT ID: NCT04120818
Last Updated: 2019-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2016-03-04
2017-02-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytokines in Femtosecond Laser-assisted Cataract Surgery
NCT05511506
Clinical Characteristics in Congenital Cataract Eyes
NCT03905044
Outcomes of 3 Incision-size-dependent Phacoemulsification Systems
NCT01429532
Effect of Phacoemulsification on Ocular Blood Flow in Human
NCT01305005
Longitudinal Changes in Refractive Error After Primary IOL Implantation Among Children With Congenital Cataract
NCT04441268
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aqueous humor (100-200 μl) was aspirated from each patient before the surgery. The research was to evaluate the relationship between the cytokine profile in aqueous humor and the state of capsule after Lensectomy and Anterior Vitrectomy.Aqueous humor was obtained , Human Magnetic Luminex Screening Assay was used to determine the aqueous humor levels of cytokines.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SIOL group
aphakic children diagnosed with congenital cataract who underwent secondary IOL implantation
secondary IOL implantation
reopened the fibrotic, closed capsular bag and achieve IOL placement
PIOL group
children with congenital cataract who underwent lensectomy and anterior vitrectomy and primary IOL implantation
primary IOL implantation
lensectomy and anterior vitrectomy and primary IOL implantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
secondary IOL implantation
reopened the fibrotic, closed capsular bag and achieve IOL placement
primary IOL implantation
lensectomy and anterior vitrectomy and primary IOL implantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
10 Months
72 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
yin ying zhao
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yin ying zhao
Clinical professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eye Hosptial of Wenzhou Medical College
Wenzhou, Zhejiang, China
Ophthalmology and Optometry Hospital
Wenzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
yyzhao
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.